{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:04:00Z","timestamp":1791993840090,"version":"4.4.0"},"reference-count":323,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008793","name":"Universidad del Rosario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jaut.2019.102375","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:54:20Z","timestamp":1575334460000},"page":"102375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["Ebola virus disease: An emerging and re-emerging viral threat"],"prefix":"10.1016","volume":"106","author":[{"given":"Manuel","family":"Rojas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Monsalve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yovana","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeny","family":"Acosta-Ampudia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Ram\u00edrez-Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab A.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Manuel","family":"Anaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2019.102375_bib1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/femsre\/fuw010","article-title":"Neglected filoviruses","volume":"40","author":"Burk","year":"2016","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.jaut.2019.102375_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41579-019-0187-4","article-title":"New filovirus disease classification and nomenclature","volume":"17","author":"Kuhn","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jaut.2019.102375_bib3","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0308","article-title":"Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013-2016","volume":"372","author":"Garske","year":"2017","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.jaut.2019.102375_bib4","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(18)33132-5","article-title":"Ebola virus disease","volume":"393","author":"Malvy","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102375_bib5","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJMc1415318","article-title":"Ebola virus disease among children in West Africa","volume":"372","author":"WHO Ebola Response Team","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib6","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3201\/eid2210.160579","article-title":"Ebola virus disease in children, Sierra Leone,","volume":"22","author":"Fitzgerald","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1056\/NEJMc1510305","article-title":"Ebola virus disease among male and female persons in West Africa","volume":"374","author":"WHO Ebola Response Team","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1411249","article-title":"Clinical presentation of patients with Ebola virus disease in Conakry, Guinea","volume":"372","author":"Bah","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib9","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41591-019-0444-0","article-title":"Understanding long-term effects of Ebola virus disease","volume":"25","author":"Chertow","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206595","article-title":"Stigma and Ebola survivorship in Liberia: results from a longitudinal cohort study","volume":"13","author":"Overholt","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102375_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1805435","article-title":"A longitudinal study of ebola sequelae in Liberia","volume":"380","author":"PREVAIL III Study Group","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib12","article-title":"A brief history of ebolavirus disease: paving the way forward by learning from the previous outbreaks","author":"Jefferies","year":"2018","journal-title":"Infect. Disord. - Drug Targets"},{"key":"10.1016\/j.jaut.2019.102375_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/jiz078","article-title":"Laboratory findings, compassionate use of favipiravir, and outcome in patients with ebola virus disease, Guinea, 2015-A retrospective observational study","volume":"220","author":"Kerber","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005389","article-title":"JIKI study group, Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted","volume":"11","author":"Nguyen","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102375_bib16","first-page":"884","article-title":"Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study","volume":"18","author":"Sivapalasingam","year":"2018","journal-title":"Inf. Disp."},{"key":"10.1016\/j.jaut.2019.102375_bib17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(19)30036-4","article-title":"VRC 608 Study team, Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study","volume":"393","author":"Gaudinski","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102375_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005491","article-title":"Estimating the number of secondary Ebola cases resulting from an unsafe burial and risk factors for transmission during the West Africa Ebola epidemic","volume":"11","author":"Tiffany","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib19","series-title":"Interim Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-Care Settings, with Focus on Ebola","author":"World Health Organization - WHO","year":"2014"},{"key":"10.1016\/j.jaut.2019.102375_bib20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/infdis\/jiz241","article-title":"V920-012 study team, immunogenicity, lot consistency, and extended safety of rVSV\u0394G-ZEBOV-GP vaccine: a phase 3 randomized, double-blind, placebo-controlled study in healthy adults","volume":"220","author":"Halperin","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib21","doi-asserted-by":"crossref","first-page":"100009","DOI":"10.1016\/j.jvacx.2019.100009","volume":"1","author":"Monath","year":"2019","journal-title":"Vaccine X"},{"key":"10.1016\/j.jaut.2019.102375_bib22","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.3390\/v6093663","article-title":"Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names","volume":"6","author":"Kuhn","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.jaut.2019.102375_bib23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00705-013-1846-9","article-title":"Discussions and decisions of the 2012\u20132014 international committee on taxonomy of viruses (ICTV) Filoviridae study group","volume":"159","author":"Bukreyev","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib24","doi-asserted-by":"crossref","DOI":"10.5812\/archneurosci.35027","article-title":"Nature and history of ebola virus: an overview","volume":"3","author":"Majid","year":"2016","journal-title":"Arch. Neurosci."},{"issue":"Pt 2","key":"10.1016\/j.jaut.2019.102375_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1099\/0022-1317-80-2-355","article-title":"Characterization of the L gene and 5\u2019 trailer region of Ebola virus","volume":"80","author":"Volchkov","year":"1999","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib26","doi-asserted-by":"crossref","first-page":"55750","DOI":"10.18632\/oncotarget.18498","article-title":"The lifecycle of the Ebola virus in host cells","volume":"8","author":"Dong-Shan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaut.2019.102375_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The pathogenesis of ebola virus disease","volume":"12","author":"Baseler","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jaut.2019.102375_bib28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/01652176.2017.1309474","article-title":"Ebola virus - epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans - an update on its 40 year's journey","volume":"37","author":"Singh","year":"2017","journal-title":"Vet. Q."},{"key":"10.1016\/j.jaut.2019.102375_bib29","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1126\/science.1259657","article-title":"Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak","volume":"345","author":"Gire","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jaut.2019.102375_bib30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tim.2013.07.006","article-title":"Structural perspective on the formation of ribonucleoprotein complex in negative-sense single-stranded RNA viruses","volume":"21","author":"Zhou","year":"2013","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jaut.2019.102375_bib31","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/JVI.80.8.3743-3751.2006","article-title":"Functional mapping of the nucleoprotein of Ebola virus","volume":"80","author":"Watanabe","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1097-2765(02)00588-9","article-title":"The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein","volume":"10","author":"Huang","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jaut.2019.102375_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s13238-015-0163-3","article-title":"Insight into the Ebola virus nucleocapsid assembly mechanism: crystal structure of Ebola virus nucleoprotein core domain at 1.8 \u00c5 resolution","volume":"6","author":"Dong","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.jaut.2019.102375_bib34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.celrep.2015.03.034","article-title":"An intrinsically disordered peptide from ebola virus VP35 controls viral RNA synthesis by modulating nucleoprotein-RNA interactions","volume":"11","author":"Leung","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.jaut.2019.102375_bib35","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1128\/JVI.78.14.7344-7351.2004","article-title":"Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles","volume":"78","author":"Licata","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib36","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1128\/JVI.77.3.1793-1800.2003","article-title":"Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding","volume":"77","author":"Han","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib37","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1038\/s41598-017-08167-8","article-title":"Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging","volume":"7","author":"Banadyga","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2019.102375_bib38","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/JVI.02349-05","article-title":"Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation","volume":"80","author":"Reid","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002550","article-title":"The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold","volume":"8","author":"Zhang","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jaut.2019.102375_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virol.2016.11.015","article-title":"Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system","volume":"501","author":"Guito","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.jaut.2019.102375_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006349","article-title":"Ebolaviruses: new roles for old proteins","volume":"12","author":"Cantoni","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4161\/viru.1.6.12984","article-title":"Ebolavirus VP35 is a multifunctional virulence factor","volume":"1","author":"Leung","year":"2010","journal-title":"Virulence"},{"key":"10.1016\/j.jaut.2019.102375_bib43","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1128\/JVI.77.14.7945-7956.2003","article-title":"The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3","volume":"77","author":"Basler","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib44","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrmicro3524","article-title":"Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus","volume":"13","author":"Messaoudi","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jaut.2019.102375_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000493","article-title":"Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery","volume":"5","author":"Chang","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jaut.2019.102375_bib46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nsmb.1765","article-title":"Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35","volume":"17","author":"Leung","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jaut.2019.102375_bib47","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1016\/j.celrep.2019.08.047","article-title":"A VP35 mutant ebola virus lacks virulence but can elicit protective immunity to wild-type virus challenge","volume":"28","author":"Woolsey","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jaut.2019.102375_bib48","doi-asserted-by":"crossref","first-page":"41830","DOI":"10.1074\/jbc.M307036200","article-title":"Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide","volume":"278","author":"Hartlieb","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2019.102375_bib49","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1073\/pnas.0606730104","article-title":"Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association","volume":"104","author":"Hartlieb","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2019.102375_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005937","article-title":"The ebola virus VP30-NP interaction is a regulator of viral RNA synthesis","volume":"12","author":"Kirchdoerfer","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jaut.2019.102375_bib51","doi-asserted-by":"crossref","first-page":"11165","DOI":"10.1074\/jbc.M113.461285","article-title":"Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication","volume":"288","author":"Biedenkopf","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2019.102375_bib52","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1128\/JVI.01160-10","article-title":"Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway","volume":"85","author":"Fabozzi","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2017.02.004","article-title":"Filovirus proteins for antiviral drug discovery: structure\/function bases of the replication cycle","volume":"141","author":"Martin","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jaut.2019.102375_bib54","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/viro.1995.0052","article-title":"GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases","volume":"214","author":"Volchkov","year":"1995","journal-title":"Virology"},{"issue":"Suppl","key":"10.1016\/j.jaut.2019.102375_bib55","doi-asserted-by":"crossref","first-page":"S941","DOI":"10.1093\/infdis\/jir321","article-title":"Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of Guinea pigs","volume":"204","author":"Volchkova","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib56","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/dna.2017.3639","article-title":"The role of exosomal VP40 in ebola virus disease","volume":"36","author":"Pleet","year":"2017","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.jaut.2019.102375_bib57","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1128\/JVI.75.11.5205-5214.2001","article-title":"Ebola virus VP40-induced particle formation and association with the lipid bilayer","volume":"75","author":"Jasenosky","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib58","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2217\/fvl.15.6","article-title":"The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target","volume":"10","author":"Madara","year":"2015","journal-title":"Future Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0042-6822(03)00260-5","article-title":"Oligomerization and polymerization of the filovirus matrix protein VP40","volume":"312","author":"Timmins","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.jaut.2019.102375_bib60","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.bpj.2012.04.022","article-title":"Investigation of ebola VP40 assembly and oligomerization in live cells using number and brightness analysis","volume":"102","author":"Adu-Gyamfi","year":"2012","journal-title":"Biophys. J."},{"key":"10.1016\/j.jaut.2019.102375_bib61","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3389\/fmicb.2016.01765","article-title":"Ebola VP40 in exosomes can cause immune cell dysfunction","volume":"7","author":"Pleet","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jaut.2019.102375_bib62","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/fvl.09.56","article-title":"Ebolavirus glycoprotein structure and mechanism of entry","volume":"4","author":"Lee","year":"2009","journal-title":"Future Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib63","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1128\/JVI.02190-10","article-title":"A new Ebola virus nonstructural glycoprotein expressed through RNA editing","volume":"85","author":"Mehedi","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib64","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/viro.1999.0034","article-title":"Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus","volume":"265","author":"Volchkova","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.jaut.2019.102375_bib65","doi-asserted-by":"crossref","first-page":"15951","DOI":"10.1074\/jbc.M601796200","article-title":"Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor","volume":"281","author":"Kuhn","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2019.102375_bib66","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1128\/JVI.01586-06","article-title":"The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity","volume":"81","author":"Zampieri","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003065","article-title":"Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus","volume":"8","author":"Mohan","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jaut.2019.102375_bib68","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1073\/pnas.96.6.2662","article-title":"Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution","volume":"96","author":"Malashkevich","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2019.102375_bib69","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00438-17","article-title":"Ebola virus delta peptide is a viroporin","volume":"91","author":"He","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib70","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/S0002-9440(10)63592-4","article-title":"Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2019.102375_bib71","doi-asserted-by":"crossref","first-page":"S1021","DOI":"10.1093\/infdis\/jir339","article-title":"Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques","volume":"204 Suppl","author":"Hensley","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib72","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1128\/JVI.76.13.6841-6844.2002","article-title":"C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans","volume":"76","author":"Alvarez","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib73","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1128\/JVI.02021-09","article-title":"Different potential of C-type lectin-mediated entry between Marburg virus strains","volume":"84","author":"Matsuno","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib74","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1038\/s41598-018-23357-8","article-title":"A critical domain of ebolavirus envelope glycoprotein determines glycoform and infectivity","volume":"8","author":"Fujihira","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2019.102375_bib75","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0807578106","article-title":"Alpha5beta1-integrin controls ebolavirus entry by regulating endosomal cathepsins","volume":"106","author":"Schornberg","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2019.102375_bib76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0092-8674(01)00418-4","article-title":"Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses","volume":"106","author":"Chan","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2019.102375_bib77","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1128\/JVI.03689-14","article-title":"Role of EXT1 and glycosaminoglycans in the early stage of filovirus entry","volume":"89","author":"O'Hearn","year":"2015","journal-title":"J. Virol."},{"issue":"Suppl","key":"10.1016\/j.jaut.2019.102375_bib78","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1093\/infdis\/jiv140","article-title":"Analysis of ebola virus entry into macrophages","volume":"212","author":"Dahlmann","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001121","article-title":"Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner","volume":"6","author":"Nanbo","year":"2010","journal-title":"PLoS Pathog."},{"issue":"Suppl","key":"10.1016\/j.jaut.2019.102375_bib80","doi-asserted-by":"crossref","first-page":"S957","DOI":"10.1093\/infdis\/jir326","article-title":"Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis","volume":"204","author":"Aleksandrowicz","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004731","article-title":"Ebola virus entry: a curious and complex series of events","volume":"11","author":"Moller-Tank","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jaut.2019.102375_bib82","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102375_bib83","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jaut.2019.102375_bib84","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/17460794.2.2.205","article-title":"Filovirus replication and transcription","volume":"2","author":"M\u00fchlberger","year":"2007","journal-title":"Future Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib85","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.virusres.2004.08.014","article-title":"Filovirus budding","volume":"106","author":"Jasenosky","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.jaut.2019.102375_bib86","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.1711470308","article-title":"Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection","volume":"147","author":"Baskerville","year":"1985","journal-title":"J. Pathol."},{"key":"10.1016\/j.jaut.2019.102375_bib87","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ni1519","article-title":"Immunopathology of highly virulent pathogens: insights from Ebola virus","volume":"8","author":"Zampieri","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2019.102375_bib88","first-page":"271","article-title":"Ebola haemorrhagic fever in Zaire, 1976","volume":"56","year":"1978","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jaut.2019.102375_bib89","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/JLB.4RI0518-183R","article-title":"The role of mononuclear phagocytes in Ebola virus infection","volume":"104","author":"Rogers","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2019.102375_bib90","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3389\/fmicb.2017.01571","article-title":"Ebola virus glycoprotein induces an innate immune response in vivo via TLR4","volume":"8","author":"Lai","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jaut.2019.102375_bib91","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.biocel.2005.02.018","article-title":"Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever","volume":"37","author":"Bray","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jaut.2019.102375_bib92","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1086\/379199","article-title":"Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation","volume":"188","author":"Bosio","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib93","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1128\/JVI.01097-07","article-title":"Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1","volume":"81","author":"Reid","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib94","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1089\/vim.2004.17.390","article-title":"Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques","volume":"17","author":"Reed","year":"2004","journal-title":"Viral Immunol."},{"key":"10.1016\/j.jaut.2019.102375_bib95","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.20032141","article-title":"Role of natural killer cells in innate protection against lethal ebola virus infection","volume":"200","author":"Warfield","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib96","doi-asserted-by":"crossref","first-page":"e01703","DOI":"10.1128\/JVI.01703-18","article-title":"NK cells accumulate in infected tissues and contribute to pathogenicity of ebola virus in mice","volume":"93","author":"Fausther-Bovendo","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib97","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.chom.2017.10.011","article-title":"Multi-platform \u2019omics analysis of human ebola virus disease pathogenesis","volume":"22","author":"Eisfeld","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jaut.2019.102375_bib98","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrneph.2016.71","article-title":"The role of neutrophils and NETosis in autoimmune and renal diseases","volume":"12","author":"Gupta","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jaut.2019.102375_bib99","doi-asserted-by":"crossref","first-page":"42147","DOI":"10.1038\/srep42147","article-title":"Ebola virus infection induces autoimmunity against dsDNA and HSP60","volume":"7","author":"Fausther-Bovendo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2019.102375_bib100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/vaccines7010011","article-title":"T-cell response to viral hemorrhagic fevers","volume":"7","author":"Perdomo-Celis","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.jaut.2019.102375_bib101","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.4049\/jimmunol.180.6.4058","article-title":"Functional CD8+ T cell responses in lethal Ebola virus infection","volume":"180","author":"Bradfute","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2019.102375_bib102","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/JVI.78.2.958-967.2004","article-title":"Persistent infection with ebola virus under conditions of partial immunity","volume":"78","author":"Gupta","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib103","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1073\/pnas.1502619112","article-title":"Human Ebola virus infection results in substantial immune activation","volume":"112","author":"McElroy","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2019.102375_bib104","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature17949","article-title":"Unique human immune signature of Ebola virus disease in Guinea","volume":"533","author":"Ruibal","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102375_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036192","article-title":"Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever","volume":"7","author":"Marzi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102375_bib106","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1209591110","article-title":"Antibodies are necessary for rVSV\/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates","volume":"110","author":"Marzi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2019.102375_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003876","article-title":"Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies","volume":"4","author":"Qiu","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib108","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"Baize","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib109","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3201\/eid1507.090402","article-title":"Immunoglobulin G in Ebola outbreak survivors, Gabon.","volume":"15","author":"Wauquier","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/infdis\/jit162","article-title":"Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu)","volume":"208","author":"Sobarzo","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib111","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virusres.2015.12.019","article-title":"Specific neutralizing response in plasma from convalescent patients of ebola virus disease against the West Africa makona variant of ebola virus","volume":"213","author":"Luczkowiak","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.jaut.2019.102375_bib112","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2019.04.036","article-title":"Longitudinal analysis of the human B cell response to ebola virus infection","volume":"177","author":"Davis","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2019.102375_bib113","article-title":"Survivors of Ebola virus disease develop polyfunctional antibody responses","author":"Gunn","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib114","first-page":"113","article-title":"Host factors involved in ebola virus replication","volume":"419","author":"Rasmussen","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jaut.2019.102375_bib115","first-page":"H736","article-title":"Cadherin-5 redistribution at sites of TNF-alpha and IFN-gamma-induced permeability in mesenteric venules","volume":"276","author":"Wong","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jaut.2019.102375_bib116","doi-asserted-by":"crossref","first-page":"10442","DOI":"10.1128\/JVI.79.16.10442-10450.2005","article-title":"Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function","volume":"79","author":"Wahl-Jensen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib117","first-page":"141","article-title":"Ebola virus disease in humans: pathophysiology and immunity","volume":"411","author":"Mu\u00f1oz-Fontela","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jaut.2019.102375_bib118","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4103\/1755-6783.179119","article-title":"Change of platelet count during hospitalization in patients with Ebola virus disease","volume":"9","author":"Wiwanitkit","year":"2016","journal-title":"Ann. Trop. Med. Public Health"},{"key":"10.1016\/j.jaut.2019.102375_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021134","article-title":"Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness","volume":"6","author":"Sundberg","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102375_bib120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2217\/1750743X.1.2.187","article-title":"Fibroblastic reticular cell infection by hemorrhagic fever viruses","volume":"1","author":"Steele","year":"2009","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jaut.2019.102375_bib121","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/0300985812469636","article-title":"Pathology of experimental aerosol Zaire ebolavirus infection in rhesus macaques","volume":"50","author":"Twenhafel","year":"2013","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.jaut.2019.102375_bib122","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1086\/379724","article-title":"Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes\/macrophages is a key event","volume":"188","author":"Geisbert","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib123","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008859","article-title":"Systematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendations","volume":"6","author":"Thorson","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaut.2019.102375_bib124","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coviro.2017.02.006","article-title":"Ebola virus persistence as a new focus in clinical research","volume":"23","author":"Caviness","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2221-1691(15)30341-5","article-title":"Ebola viral disease: a review literature","volume":"5","author":"Moghadam","year":"2015","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.jaut.2019.102375_bib126","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1126\/science.290.5493.923","article-title":"Emerging diseases. On the trail of Ebola and Marburg viruses","volume":"290","author":"Balter","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jaut.2019.102375_bib127","first-page":"247","article-title":"Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO\/international study team","volume":"56","year":"1978","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jaut.2019.102375_bib128","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1213\/ANE.0000000000000866","article-title":"Ebola virus disease: a review of its past and present","volume":"121","author":"Murray","year":"2015","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jaut.2019.102375_bib129","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(77)92002-5","article-title":"Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire","volume":"1","author":"Pattyn","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102375_bib130","first-page":"49","article-title":"Ebola Reston in pigs and humans, Philippines","volume":"84","author":"Outbreak news","year":"2009","journal-title":"Relev. Epidemiol. Hebd."},{"key":"10.1016\/j.jaut.2019.102375_bib131","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1126\/science.1172705","article-title":"Discovery of swine as a host for the Reston ebolavirus","volume":"325","author":"Barrette","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jaut.2019.102375_bib132","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0140-6736(95)90925-7","article-title":"Isolation and partial characterisation of a new strain of Ebola virus","volume":"345","author":"Le Guenno","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102375_bib133","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cll.2009.12.001","article-title":"Ebola and marburg hemorrhagic fever","volume":"30","author":"Hartman","year":"2010","journal-title":"Clin. Lab. Med."},{"issue":"Suppl","key":"10.1016\/j.jaut.2019.102375_bib134","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1086\/514290","article-title":"Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues","volume":"179","author":"Georges","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"Suppl","key":"10.1016\/j.jaut.2019.102375_bib135","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1086\/514306","article-title":"The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epid\u00e9mies \u00e0 Kikwit","volume":"179","author":"Khan","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib136","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1046\/j.1365-3156.2002.00944.x","article-title":"An outbreak of Ebola in Uganda","volume":"7","author":"Okware","year":"2002","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.jaut.2019.102375_bib137","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.micinf.2005.04.006","article-title":"The natural history of Ebola virus in Africa","volume":"7","author":"Pourrut","year":"2005","journal-title":"Microb. Infect."},{"key":"10.1016\/j.jaut.2019.102375_bib138","first-page":"291","article-title":"[Outbreak of Ebola hemorrhagic fever in the Republic of the Congo, 2003: a new strategy?]","volume":"63","author":"Formenty","year":"2003","journal-title":"Med. Trop. (Mars)"},{"issue":"Suppl","key":"10.1016\/j.jaut.2019.102375_bib139","doi-asserted-by":"crossref","first-page":"S761","DOI":"10.1093\/infdis\/jir294","article-title":"Filovirus outbreak detection and surveillance: lessons from Bundibugyo","volume":"204","author":"MacNeil","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib140","series-title":"WHO | Ebola Virus Disease \u2013 Italy","year":"2015"},{"key":"10.1016\/j.jaut.2019.102375_bib141","series-title":"WHO | End of Ebola Outbreak in the Democratic Republic of the Congo","year":"2015"},{"key":"10.1016\/j.jaut.2019.102375_bib142","series-title":"WHO | Ebola Haemorrhagic Fever in the Republic of the Congo - Update 6","year":"2015"},{"key":"10.1016\/j.jaut.2019.102375_bib143","doi-asserted-by":"crossref","first-page":"4","DOI":"10.15585\/mmwr.su6503a2","article-title":"Overview, control strategies, and lessons learned in the CDC response to the 2014-2016 ebola epidemic","volume":"65","author":"Bell","year":"2016","journal-title":"MMWR Suppl"},{"key":"10.1016\/j.jaut.2019.102375_bib144","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3201\/eid1809.111536","article-title":"Reemerging Sudan Ebola virus disease in Uganda","volume":"18","author":"Shoemaker","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.virol.2013.04.014","article-title":"Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012","volume":"442","author":"Albari\u00f1o","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.jaut.2019.102375_bib146","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1411099","article-title":"Ebola virus disease in the democratic republic of Congo","volume":"371","author":"Maganga","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib147","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.2.6086.541","article-title":"A case of Ebola virus infection","volume":"2","author":"Emond","year":"1977","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jaut.2019.102375_bib148","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/142.3.372","article-title":"Ebola hemorrhagic fever: tandala, Zaire, 1977-1978","volume":"142","author":"Heymann","year":"1980","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib149","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0140-6736(91)91199-5","article-title":"Seroepidemiological study of filovirus related to Ebola in the Philippines","volume":"337","author":"Miranda","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102375_bib150","first-page":"997","article-title":"Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread","volume":"61","author":"Baron","year":"1983","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jaut.2019.102375_bib151","first-page":"221","article-title":"Update: filovirus infection in animal handlers","volume":"39","author":"Centers for Disease Control (CDC)","year":"1990","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.jaut.2019.102375_bib152","series-title":"WHO | Ebola Virus Disease \u2013 Spain","year":"2015"},{"key":"10.1016\/j.jaut.2019.102375_bib153","doi-asserted-by":"crossref","first-page":"17","DOI":"10.15252\/emmm.201404792","article-title":"Investigating the zoonotic origin of the West african ebola epidemic","volume":"7","author":"Mar\u00ed Sa\u00e9z","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib154","article-title":"Filovirus disease outbreaks: a chronological overview","volume":"10","author":"Languon","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.jaut.2019.102375_bib155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.364.6437.223","article-title":"Ebola outbreak continues despite powerful vaccine","volume":"364","author":"Cohen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jaut.2019.102375_bib156","series-title":"2018 Democratic Republic of the Congo","year":"2018"},{"key":"10.1016\/j.jaut.2019.102375_bib157","series-title":"Ebola situation reports. Ebola virus disease \u2013 democratic Republic of the Congo","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.jaut.2019.102375_bib158","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.tim.2007.08.001","article-title":"The ecology of Ebola virus","volume":"15","author":"Groseth","year":"2007","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jaut.2019.102375_bib159","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1179\/136485906X97426","article-title":"Climate change and health: global to local influences on disease risk","volume":"100","author":"Patz","year":"2006","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.jaut.2019.102375_bib160","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/438575a","article-title":"Fruit bats as reservoirs of Ebola virus","volume":"438","author":"Leroy","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102375_bib161","article-title":"Dead or alive: animal sampling during Ebola hemorrhagic fever outbreaks in humans","volume":"5","author":"Olson","year":"2012","journal-title":"Emerg. Health Threats J."},{"key":"10.1016\/j.jaut.2019.102375_bib162","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.crvi.2016.09.005","article-title":"Comparative phylogeography of African fruit bats (Chiroptera, Pteropodidae) provide new insights into the outbreak of Ebola virus disease in West Africa, 2014-2016","volume":"339","author":"Hassanin","year":"2016","journal-title":"C. R. Biol."},{"key":"10.1016\/j.jaut.2019.102375_bib163","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1016\/j.biocon.2011.09.003","article-title":"Uncovering the fruit bat bushmeat commodity chain and the true extent of fruit bat hunting in Ghana, West Africa","volume":"144","author":"Kamins","year":"2011","journal-title":"Biol. Conserv."},{"key":"10.1016\/j.jaut.2019.102375_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005780","article-title":"Ecological contexts of index cases and spillover events of different ebolaviruses","volume":"12","author":"Judson","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jaut.2019.102375_bib165","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1286-4579(99)00242-7","article-title":"Identification of Ebola virus sequences present as RNA or DNA in organs of terrestrial small mammals of the Central African Republic","volume":"1","author":"Morvan","year":"1999","journal-title":"Microb. Infect."},{"key":"10.1016\/j.jaut.2019.102375_bib166","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3201\/eid1102.040533","article-title":"Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo","volume":"11","author":"Rouquet","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib167","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3390\/v6041759","article-title":"Filoviruses in bats: current knowledge and future directions","volume":"6","author":"Olival","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.jaut.2019.102375_bib168","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.aogh.2015.02.005","article-title":"Transmission of ebola virus disease: an overview","volume":"80","author":"Rewar","year":"2014","journal-title":"Ann. Glob. Heal."},{"key":"10.1016\/j.jaut.2019.102375_bib169","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1056\/NEJMoa1511410","article-title":"Ebola RNA persistence in semen of ebola virus disease survivors - final report","volume":"377","author":"Deen","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib170","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1093\/infdis\/jiw254","article-title":"Ebola virus shedding and transmission: review of current evidence","volume":"214","author":"Vetter","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib171","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/ciw793","article-title":"Ebola virus persistence in breast milk after No reported illness: a likely source of virus transmission from mother to child","volume":"64","author":"Sissoko","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib172","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cnur.2019.02.001","article-title":"Ebola virus disease: clinical challenges, recognition, and management","volume":"54","author":"Beam","year":"2019","journal-title":"Nurs. Clin. N. Am."},{"key":"10.1016\/j.jaut.2019.102375_bib173","doi-asserted-by":"crossref","DOI":"10.3201\/eid1612.100627","article-title":"Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda","volume":"16","author":"MacNeil","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib174","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMoa1411100","article-title":"Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections","volume":"371","author":"WHO Ebola Response Team","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(18)31387-4","article-title":"Outbreak of ebola virus disease in the democratic republic of the Congo, april-may, 2018: an epidemiological study","volume":"392","author":"Ebola Outbreak Epidemiology Team","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102375_bib176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005087","article-title":"Minimally symptomatic infection in an ebola \u201chotspot\u201d: a cross-sectional serosurvey","volume":"10","author":"Richardson","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib177","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(17)30234-7","article-title":"Insights from clinical research completed during the west Africa Ebola virus disease epidemic","volume":"17","author":"Rojek","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib178","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13054-016-1325-2","article-title":"Ebola virus disease and critical illness","volume":"20","author":"Leligdowicz","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.jaut.2019.102375_bib179","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1753495X15597354","article-title":"Ebola viral disease and pregnancy","volume":"8","author":"Black","year":"2015","journal-title":"Obstet. Med."},{"issue":"Suppl","key":"10.1016\/j.jaut.2019.102375_bib180","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1086\/514289","article-title":"Ebola hemorrhagic fever and pregnancy","volume":"179","author":"Mupapa","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib181","article-title":"Predicting ebola severity: a clinical prioritization score for ebola virus disease","volume":"11","author":"Hartley","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib182","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1411680","article-title":"KGH lassa fever program, viral hemorrhagic fever consortium, WHO clinical response team, clinical illness and outcomes in patients with ebola in Sierra Leone","volume":"371","author":"Schieffelin","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib183","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/cid\/ciw601","article-title":"Resurgence of ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days","volume":"63","author":"Diallo","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib184","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1500306","article-title":"Persistence of ebola virus in ocular fluid during convalescence","volume":"372","author":"Varkey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib185","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1016\/j.ophtha.2016.07.013","article-title":"Long-term management of panuveitis and Iris heterochromia in an ebola survivor","volume":"123","author":"Shantha","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaut.2019.102375_bib186","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1473-3099(16)30516-3","article-title":"Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study","volume":"17","author":"Etard","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib187","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3201\/eid2201.151212","article-title":"Ebola virus disease complicated by late-onset encephalitis and polyarthritis, Sierra Leone.","volume":"22","author":"Howlett","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib188","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1586\/14787210.2015.1079128","article-title":"Post-Ebolavirus disease syndrome: what do we know?","volume":"13","author":"Carod-Artal","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.jaut.2019.102375_bib189","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/rheumatology\/kex074","article-title":"Characteristics of the musculoskeletal symptoms observed among survivors of Ebola virus disease in the Postebogui cohort in Guinea","volume":"56","author":"Pers","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2019.102375_bib190","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S1473-3099(15)70152-0","article-title":"Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study","volume":"15","author":"V Clark","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib191","first-page":"338","article-title":"Clinical characteristics of ebola survivors 40 years post infection in the democratic republic of Congo","volume":"95","author":"Mwanza","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jaut.2019.102375_bib192","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/cid\/ciw158","article-title":"Ebola virus disease complications as experienced by survivors in Sierra Leone","volume":"62","author":"Tiffany","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib193","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1016\/S2214-109X(16)30147-4","article-title":"Pregnancy outcomes in Liberian women who conceived after recovery from Ebola virus disease","volume":"4","author":"Fallah","year":"2016","journal-title":"Lancet. Glob. Health"},{"key":"10.1016\/j.jaut.2019.102375_bib194","first-page":"641","article-title":"Post-Ebola syndrome, Sierra Leone., emerg","volume":"22","author":"Scott","year":"2016","journal-title":"Inf. Disp."},{"key":"10.1016\/j.jaut.2019.102375_bib195","first-page":"4145","article-title":"Patterns of ocular manifestations in ebola virus disease survivors in the Port Loko, Sierra Leone","volume":"57","author":"Vandy","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jaut.2019.102375_bib196","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1473-3099(15)00489-2","article-title":"Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study","volume":"16","author":"Mattia","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib197","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12888-017-1280-8","article-title":"Depressive symptoms among survivors of Ebola virus disease in Conakry (Guinea): preliminary results of the PostEboGui cohort","volume":"17","author":"Keita","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jaut.2019.102375_bib198","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ajo.2016.12.005","article-title":"Ocular complications in survivors of the ebola outbreak in Guinea","volume":"175","author":"Hereth-Hebert","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2019.102375_bib199","article-title":"Factors associated with uveitis among Ebola survivors in the PREVAIL III study","volume":"58","author":"Eghrari","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jaut.2019.102375_bib200","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ophtha.2016.10.011","article-title":"Ophthalmic manifestations and causes of vision impairment in ebola virus disease survivors in monrovia, Liberia.","volume":"124","author":"Shantha","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaut.2019.102375_bib201","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.evopsy.2016.07.004","article-title":"Survivors of epidemic recent disease Ebola virus in psychiatric hospital service national Donka in Guinea: psychopathological and psychotherapeutic study","volume":"82","author":"Keita","year":"2017","journal-title":"Evol. Psychiatr."},{"key":"10.1016\/j.jaut.2019.102375_bib202","article-title":"Ebola virus persistence in ocular tissues and fluids (EVICT) study: baseline characteristics and primary findings from ocular fluid of ebola survivors in Sierra Leone","volume":"58","author":"Yeh","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jaut.2019.102375_bib203","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3201\/eid2307.161608","article-title":"Novel retinal lesion in ebola survivors, Sierra Leone","volume":"23","author":"Steptoe","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib204","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1007\/s10096-017-3045-1","article-title":"Mobile health clinic for the medical management of clinical sequelae experienced by survivors of the 2013-2016 Ebola virus disease outbreak in Sierra Leone, West Africa","volume":"36","author":"Guetiya Wadoum","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib205","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2017.03181","article-title":"Ocular inflammatory diseases in ebola survivors","volume":"95","author":"Hereth","year":"2017","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jaut.2019.102375_bib206","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3201\/eid2301.161631","article-title":"Sequelae and other conditions in ebola virus disease survivors, Sierra Leone","volume":"23","author":"Mohammed","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib207","doi-asserted-by":"crossref","first-page":"1909410","DOI":"10.1155\/2018\/1909410","article-title":"Post-Ebola syndrome among ebola virus disease survivors in montserrado county, Liberia 2016","volume":"2018","author":"Wilson","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jaut.2019.102375_bib208","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209655","article-title":"Surviving Ebola: a historical cohort study of Ebola mortality and survival in Sierra Leone 2014-2015","volume":"13","author":"Wing","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102375_bib209","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/cid\/cix705","article-title":"Disability among ebola survivors and their close contacts in Sierra Leone: a retrospective case-controlled cohort study","volume":"66","author":"Jagadesh","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib210","first-page":"4171","article-title":"Burden, timing, and outcomes of uveitis from a retrospective cohort of Ebola survivors in Sierra Leone","volume":"59","author":"Vandy","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jaut.2019.102375_bib211","first-page":"1428","article-title":"Ocular complications in pediatric ebola survivors","volume":"27","author":"Shantha","year":"2018","journal-title":"J. Women\u2019s Health"},{"key":"10.1016\/j.jaut.2019.102375_bib212","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3201\/eid2408.171367","article-title":"Case series of severe neurologic sequelae of ebola virus disease during epidemic, Sierra Leone.","volume":"24","author":"Howlett","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib213","doi-asserted-by":"crossref","first-page":"ofy239","DOI":"10.1093\/ofid\/ofy239","article-title":"Care of ebola survivors and factors associated with clinical sequelae-monrovia, Liberia","volume":"5","author":"de St Maurice","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib214","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/cid\/ciy677","article-title":"Neurological, cognitive, and psychological findings among survivors of ebola virus disease from the 1995 ebola outbreak in Kikwit, democratic republic of Congo: a cross-sectional study","volume":"68","author":"Kelly","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib215","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ijgo.12858","article-title":"Reproductive health sequelae among women who survived Ebola virus disease in Liberia","volume":"146","author":"Godwin","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"Suppl","key":"10.1016\/j.jaut.2019.102375_bib216","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/514318","article-title":"Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epid\u00e9mies \u00e0 Kikwit","volume":"179","author":"Rowe","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"Suppl","key":"10.1016\/j.jaut.2019.102375_bib217","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/514308","article-title":"Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients","volume":"179","author":"Bwaka","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"Suppl","key":"10.1016\/j.jaut.2019.102375_bib218","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1086\/514288","article-title":"Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo","volume":"179","author":"Kibadi","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib219","first-page":"435","article-title":"A case series of 11 uveitis in patients who recovered from Ebola in Guinea","volume":"20","author":"Hereth H\u00e9bert","year":"2015","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.jaut.2019.102375_bib220","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMc1506576","article-title":"Post-Ebola signs and symptoms in U.S. Survivors.","volume":"373","author":"Epstein","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib221","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/cid\/civ453","article-title":"Study of ebola virus disease survivors in Guinea","volume":"61","author":"Qureshi","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib222","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/rheumatology\/kex082","article-title":"Musculoskeletal manifestations of Ebola virus","volume":"57","author":"Amissah-Arthur","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2019.102375_bib223","first-page":"669","article-title":"Association of ebola virus infection with hearing loss in regions where ebola virus infection is endemic: a systematic review","volume":"145","author":"Xu","year":"2019","journal-title":"JAMA Otolaryngol"},{"issue":"Suppl","key":"10.1016\/j.jaut.2019.102375_bib224","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1086\/514321","article-title":"Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo","volume":"179","author":"Ksiazek","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib225","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1093\/infdis\/jiw246","article-title":"Evaluation of RealStar reverse transcription-polymerase chain reaction kits for filovirus detection in the laboratory and field","volume":"214","author":"Rieger","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib226","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1128\/JCM.39.11.4125-4130.2001","article-title":"Development and evaluation of a fluorogenic 5\u2019 nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan","volume":"39","author":"Gibb","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jaut.2019.102375_bib227","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/JCM.02724-15","article-title":"Comparative evaluation of the diagnostic performance of the prototype cepheid GeneXpert ebola assay","volume":"54","author":"Jansen van Vuren","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jaut.2019.102375_bib228","article-title":"Correction: analytical performance characteristics of the cepheid GeneXpert ebola assay for the detection of ebola virus","volume":"10","author":"Pinsky","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102375_bib229","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006135","article-title":"Establishing Ebola Virus Disease (EVD) diagnostics using GeneXpert technology at a mobile laboratory in Liberia: impact on outbreak response, case management and laboratory systems strengthening","volume":"12","author":"Raftery","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib230","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(15)61042-X","article-title":"ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study","volume":"386","author":"Broadhurst","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102375_bib231","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.cmi.2017.10.019","article-title":"EBOLA Ag K-SeT rapid test: field evaluation in Sierra Leone","volume":"24","author":"Colavita","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jaut.2019.102375_bib232","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001908","article-title":"Use of viremia to evaluate the baseline case fatality ratio of ebola virus disease and inform treatment studies: a retrospective cohort study","volume":"12","author":"Faye","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.jaut.2019.102375_bib233","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/JVI.78.8.4330-4341.2004","article-title":"Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome","volume":"78","author":"Towner","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib234","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1172\/JCI83162","article-title":"Ebola viral load at diagnosis associates with patient outcome and outbreak evolution","volume":"125","author":"de La Vega","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2019.102375_bib235","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1172\/JCI83111","article-title":"Blood kinetics of Ebola virus in survivors and nonsurvivors","volume":"125","author":"Lanini","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2019.102375_bib236","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1473-3099(17)30111-1","article-title":"Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus","volume":"17","author":"Glynn","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib237","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/S0140-6736(00)02405-3","article-title":"Human asymptomatic Ebola infection and strong inflammatory response","volume":"355","author":"Leroy","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102375_bib238","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1086\/503836","article-title":"Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo","volume":"42","author":"Formenty","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib239","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/cid\/civ1024","article-title":"Dilemmas in managing pregnant women with ebola: 2 case reports","volume":"62","author":"Caluwaerts","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib240","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/cid\/ciw202","article-title":"Ebola virus persistence in semen of male survivors","volume":"62","author":"Uyeki","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib241","doi-asserted-by":"crossref","first-page":"S250","DOI":"10.1093\/infdis\/jiw269","article-title":"Analysis of diagnostic findings from the European mobile laboratory in gu\u00e9ck\u00e9dou, Guinea, march 2014 through march 2015","volume":"214","author":"Kerber","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib242","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1093\/infdis\/jiw296","article-title":"Ebola virus disease diagnostics, Sierra Leone: analysis of real-time reverse transcription-polymerase chain reaction values for clinical blood and oral swab specimens","volume":"214","author":"Erickson","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib243","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102375_bib244","first-page":"93","article-title":"Clinical management of ebola virus disease patients in low-resource settings","volume":"411","author":"Sprecher","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jaut.2019.102375_bib245","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1056\/NEJMoa1504874","article-title":"Working group of the U.S.\u2013European clinical network on clinical management of ebola virus disease patients in the U.S. and europe, clinical management of ebola virus disease in the United States and europe","volume":"374","author":"Uyeki","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"Suppl","key":"10.1016\/j.jaut.2019.102375_bib246","doi-asserted-by":"crossref","first-page":"S390","DOI":"10.1086\/520598","article-title":"Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever","volume":"196","author":"Hensley","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib247","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(03)15012-X","article-title":"Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa\/tissue factor: a study in rhesus monkeys","volume":"362","author":"Geisbert","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102375_bib248","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/phar.1545","article-title":"Treatment of ebola virus disease","volume":"35","author":"Kilgore","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaut.2019.102375_bib249","series-title":"Potential Ebola Therapies and Vaccines","author":"World Health Organization - WHO","year":"2014"},{"key":"10.1016\/j.jaut.2019.102375_bib250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1871526518666180813160348","article-title":"Ebola therapeutic study and future directions","volume":"19","author":"Lu","year":"2019","journal-title":"Infect. Disord. - Drug Targets"},{"key":"10.1016\/j.jaut.2019.102375_bib251","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-4939-7116-9_13","article-title":"Generation of recombinant ebola viruses using reverse genetics","volume":"1628","author":"Groseth","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jaut.2019.102375_bib252","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9875","article-title":"Two-mAb cocktail protects macaques against the Makona variant of Ebola virus","volume":"8","author":"Qiu","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib253","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","article-title":"A randomized, controlled trial of ZMapp for ebola virus infection","volume":"375","author":"PREVAIL II Writing Group","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib254","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102375_bib255","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw460","article-title":"Adeno-associated virus serotype 9-expressed ZMapp in mice confers protection against systemic and airway-acquired ebola virus infection","volume":"214","author":"Limberis","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib256","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1089\/hum.2017.101","article-title":"Gene transfer of ZMapp antibodies mediated by recombinant adeno-associated virus protects against ebola infections","volume":"29","author":"Robert","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jaut.2019.102375_bib257","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/infdis\/jiy230","article-title":"ZMapp reinforces the airway mucosal barrier against ebola virus","volume":"218","author":"Yang","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib258","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/infdis\/jiy285","article-title":"Development of clinical-stage human monoclonal antibodies that treat advanced ebola virus disease in nonhuman primates","volume":"218","author":"Pascal","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib259","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/cid\/ciw256","article-title":"Use of postexposure prophylaxis After occupational exposure to Zaire ebolavirus","volume":"63","author":"Wong","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001997","article-title":"RAPIDE-TKM trial team, experimental treatment of ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial","volume":"13","author":"Dunning","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.jaut.2019.102375_bib261","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/cid\/civ334","article-title":"The use of TKM-100802 and convalescent plasma in 2 patients with ebola virus disease in the United States","volume":"61","author":"Kraft","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib262","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102375_bib263","first-page":"171","article-title":"First newborn baby to receive experimental therapies survives ebola virus disease","volume":"215","author":"D\u00f6rnemann","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib264","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.jmedchem.6b01594","article-title":"Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of ebola and emerging viruses","volume":"60","author":"Siegel","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jaut.2019.102375_bib265","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jiph.2016.04.002","article-title":"BCX4430 - a broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease","volume":"9","author":"Taylor","year":"2016","journal-title":"J. Infect. Public Health."},{"key":"10.1016\/j.jaut.2019.102375_bib266","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/cid\/ciw571","article-title":"Clinical and virological characteristics of ebola virus disease patients treated with favipiravir (T-705)-Sierra Leone, 2014","volume":"63","author":"Bai","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib267","article-title":"Experimental treatment with favipiravir for ebola virus disease (the JIKI trial): a historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.jaut.2019.102375_bib268","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002535","article-title":"Antiviral efficacy of favipiravir against Ebola virus: a translational study in cynomolgus macaques","volume":"15","author":"Guedj","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.jaut.2019.102375_bib269","doi-asserted-by":"crossref","DOI":"10.3390\/v11020137","article-title":"Filovirus virulence in interferon \u03b1\/\u03b2 and \u03b3 double knockout mice, and treatment with favipiravir","volume":"11","author":"Comer","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.jaut.2019.102375_bib270","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jaut.2019.102375_bib271","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.antiviral.2017.12.020","article-title":"Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus","volume":"151","author":"Bixler","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jaut.2019.102375_bib272","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2018.01.011","article-title":"Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model","volume":"151","author":"Zhu","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jaut.2019.102375_bib273","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3390\/v4112806","article-title":"Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections","volume":"4","author":"Iversen","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.jaut.2019.102375_bib274","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1128\/AAC.03442-14","article-title":"Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studies","volume":"58","author":"Heald","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jaut.2019.102375_bib275","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.antiviral.2015.10.010","article-title":"The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus","volume":"125","author":"McMullan","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jaut.2019.102375_bib276","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162199","article-title":"RAPIDE-BCV trial team, experimental treatment of ebola virus disease with brincidofovir","volume":"11","author":"Dunning","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102375_bib277","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/civ395","article-title":"Administration of brincidofovir and convalescent plasma in a patient with ebola virus disease","volume":"61","author":"Florescu","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib278","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(14)62384-9","article-title":"Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care","volume":"385","author":"Wolf","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102375_bib279","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/infdis\/jiy199","article-title":"Anti-Ebola virus antibody levels in convalescent plasma and viral load after plasma infusion in patients with ebola virus disease","volume":"218","author":"Brown","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib280","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1093\/infdis\/jiw333","article-title":"Passive immunotherapy: assessment of convalescent serum against ebola virus makona infection in nonhuman primates","volume":"214","author":"Mire","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib281","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1740774515621056","article-title":"Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak","volume":"13","author":"Edwards","year":"2016","journal-title":"Clin. Trials"},{"key":"10.1016\/j.jaut.2019.102375_bib282","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1511812","article-title":"Ebola-tx consortium, evaluation of convalescent plasma for ebola virus disease in Guinea","volume":"374","author":"van Griensven","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib283","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.aad5224","article-title":"Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody","volume":"351","author":"Corti","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jaut.2019.102375_bib284","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2007.12.008","article-title":"Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses","volume":"78","author":"Spurgers","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jaut.2019.102375_bib285","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1128\/JVI.01490-15","article-title":"Mechanism of binding to ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies","volume":"89","author":"Davidson","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib286","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/infdis\/jiq025","article-title":"High-dose mannose-binding lectin therapy for Ebola virus infection","volume":"203","author":"Michelow","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"Suppl","key":"10.1016\/j.jaut.2019.102375_bib287","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1093\/infdis\/jiv223","article-title":"Novel small molecule entry inhibitors of ebola virus","volume":"212","author":"Basu","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib288","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann\u2013Pick C1 is essential for Ebola virus infection","volume":"477","author":"C\u00f4t\u00e9","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102375_bib289","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1073\/pnas.1019030108","article-title":"T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus","volume":"108","author":"Kondratowicz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2019.102375_bib290","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006605","article-title":"mAbs and Ad-vectored IFN-\u03b1 therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms","volume":"5","author":"Qiu","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib291","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/infdis\/jis921","article-title":"Interferon-\u03b2 therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever","volume":"208","author":"Smith","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib292","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0264-410X(00)00113-4","article-title":"Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect Guinea pigs and mice from Ebola hemorrhagic fever virus","volume":"19","author":"Pushko","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.jaut.2019.102375_bib293","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1128\/JVI.75.6.2660-2664.2001","article-title":"Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein","volume":"75","author":"Wilson","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib294","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1128\/JVI.03361-12","article-title":"Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus","volume":"87","author":"Herbert","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib295","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102375_bib296","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102375_bib297","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.vaccine.2010.10.037","article-title":"VRC 205 Study Team, A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults","volume":"29","author":"Ledgerwood","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jaut.2019.102375_bib298","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/S0140-6736(15)60553-0","article-title":"Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial","volume":"385","author":"Zhu","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102375_bib299","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"Stanley","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib300","first-page":"776","article-title":"Chimpanzee adenovirus vector ebola vaccine--preliminary report","volume":"373","author":"Ledgerwood","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib301","first-page":"1","article-title":"A monovalent chimpanzee adenovirus Ebola vaccine\u2014preliminary report","author":"Rampling","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib302","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(15)00362-X","article-title":"Use of Chad3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-bli","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib303","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1128\/JVI.02407-10","article-title":"Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge","volume":"85","author":"Geisbert","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib304","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/infdis\/jiz070","article-title":"Safety and immunogenicity of a 2-dose heterologous vaccination regimen with Ad26.ZEBOV and MVA-BN-filo ebola vaccines: 12-month data from a phase 1 randomized clinical trial in Uganda and Tanzania","volume":"220","author":"Anywaine","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib305","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/21645515.2016.1225637","article-title":"Ebola vaccines in clinical trial: the promising candidates","volume":"13","author":"Wang","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.jaut.2019.102375_bib306","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib307","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib308","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 trials of rVSV ebola vaccine in Africa and europe","volume":"374","author":"Agnandji","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102375_bib309","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","article-title":"VSV-Ebola Consortium, the effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial","volume":"15","author":"Huttner","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib310","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41598-017-01032-8","article-title":"Transcriptomic analysis reveals a previously unknown role for CD8+ T-cells in rVSV-EBOV mediated protection","volume":"7","author":"Menicucci","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2019.102375_bib311","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/JVI.80.5.2267-2279.2006","article-title":"A single intranasal inoculation with a paramyxovirus-vectored vaccine protects Guinea pigs against a lethal-dose Ebola virus challenge","volume":"80","author":"Bukreyev","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib312","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/JVI.00105-07","article-title":"Successful topical respiratory tract immunization of primates against Ebola virus","volume":"81","author":"Bukreyev","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib313","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.virol.2010.01.015","article-title":"Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic","volume":"399","author":"Bukreyev","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.jaut.2019.102375_bib314","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(80)92352-1","article-title":"Inactivated vaccine for Ebola virus efficacious in guineapig model","volume":"2","author":"Lupton","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102375_bib315","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1128\/JVI.76.18.9176-9185.2002","article-title":"Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells","volume":"76","author":"Rao","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2019.102375_bib316","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/infdis\/jiu511","article-title":"VRC 206 Study Team, Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial","volume":"211","author":"Sarwar","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib317","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(14)62385-0","article-title":"RV 247 Study Team, Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial","volume":"385","author":"Kibuuka","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102375_bib318","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1016\/j.vaccine.2019.05.026","article-title":"Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice","volume":"37","author":"Sunay","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jaut.2019.102375_bib319","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118881","article-title":"Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles","volume":"10","author":"Warfield","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102375_bib320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006461","article-title":"\u201cWhen Ebola enters a home, a family, a community\u201d: a qualitative study of population perspectives on Ebola control measures in rural and urban areas of Sierra Leone","volume":"12","author":"Gray","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib321","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006762","article-title":"Contact tracing performance during the Ebola epidemic in Liberia, 2014-2015","volume":"12","author":"Swanson","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.jaut.2019.102375_bib322","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3325\/cmj.2015.56.496","article-title":"The communication aspects of the Ebola virus disease outbreak in Western Africa--do we need to counter one, two, or many epidemics?","volume":"56","author":"Allgaier","year":"2015","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.jaut.2019.102375_bib323","series-title":"MSF Says Lack of Public Health Messages on Ebola \u201cBig Mistake","author":"Misha","year":"2015"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119306572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119306572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:24:14Z","timestamp":1760257454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119306572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":323,"alternative-id":["S0896841119306572"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102375","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ebola virus disease: An emerging and re-emerging viral threat","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102375"}}